Michael Mizhiritskii

This inventor holds 10 USPTO granted patents and 3 published patent applications and 5 EPO patents. Top assignees: Mapi Pharma Ltd., Eloxx Pharmaceuticals Ltd.. Active years: 2013-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael Mizhiritskii. Retrieved from https://idiyas.com/inventor/michael-mizhiritskii

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 (Patent Applications = 3)

% Patents Active = 60.0

EPO Patents = 5 (Patent Applications = 11)

Average Co-Inventor Count = 2.8

ph-index = 2

Forward Citations = 9(Granted Patents)

Company Filing History:

Eloxx Pharmaceuticals Ltd.

patents

Years Active: 2013-2021

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11136345 - Large scale preparation of pseudo-trisaccharide aminoglycosides and of intermediates thereof (2021-10-05),

2. 9102592 - Intermediate compounds and processes for the preparation of quinoline derivatives such as laquinimod sodium (2015-08-11),

3. 8981095 - Intermediate compounds and process for the preparation of lurasidone and salts thereof (2015-03-17),

4. 8975244 - Process and intermediates for the preparation of abiraterone acetate (2015-03-10),

5. 8865742 - Intermediate compounds and processes for the preparation of quinoline derivatives such as Laquinimod sodium (2014-10-21),

6. 8841447 - Process for the preparation of alogliptin (2014-09-23),

7. 8829208 - Process for the preparation of darunavir and darunavir intermediates (2014-09-09),

8. 8772503 - Processes for the preparation of deferasirox, and deferasirox polymorphs (2014-07-08),

9. 8735627 - Intermediate compounds and process for the preparation of fingolimod (2014-05-27),

10. 8410176 - Intermediate compounds and processes for the preparation of tapentadol and related compounds (2013-04-02),

Title: Michael Mizhiritskii: Innovator in Pharmaceutical Chemistry

Introduction

Michael Mizhiritskii is a prominent inventor based in Rehovot, Israel. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds and synthetic pathways. With a total of 10 patents to his name, Mizhiritskii's work has advanced the understanding and preparation of complex chemical structures.

Latest Patents

Mizhiritskii's latest patents include innovative methods for the large-scale preparation of pseudo-trisaccharide aminoglycosides. These patents detail synthetic pathways for creating pseudo-trisaccharide aminoglycoside compounds, as well as processes for stereoselectively preparing specific compounds while avoiding chromatographic separation of stereoisomers. Additionally, he has developed processes for preparing quinoline derivatives, such as laquinimod sodium, which are crucial in pharmaceutical applications.

Career Highlights

Throughout his career, Mizhiritskii has worked with notable companies in the pharmaceutical industry, including Mapi Pharma Ltd. and Eloxx Pharmaceuticals Ltd. His expertise in synthetic chemistry has positioned him as a valuable asset in the development of new therapeutic agents.

Collaborations

Mizhiritskii has collaborated with esteemed colleagues, including Ehud Marom and Shai Rubnov. These partnerships have fostered innovation and have contributed to the successful development of his patented technologies.

Conclusion

Michael Mizhiritskii's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to influence the development of new therapeutic compounds and processes.

Profile summary based on public USPTO records.